As of 2025-09-17, the Fair Value of Arcutis Biotherapeutics Inc (ARQT) is -3.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.97 USD, the upside of Arcutis Biotherapeutics Inc is -122.92%.
With the market price of 16.97 USD and our fair value calculation, Arcutis Biotherapeutics Inc (ARQT) is not a good investment. Investing in Arcutis stocks now will result in a potential loss of 122.92%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -135.68 | -206.36 | -311.46 | -262.14 | -140.04 | -211.14 |
| YoY growth | -223.05% | -52.09% | -50.93% | 15.84% | 46.58% | -52.73% |
| Market Cap (mil) | 2,034.87 |
| P/E | |
| Forward P/E |
| EPS | -0.78 |
| Avg earnings growth rate | -52.73% |
| TTM earnings | -93.27 |